SVB Leerink Downgrades Agios Pharma (AGIO) to Market Perform as Sickle Cell Program Delayed to 2022
Go back to SVB Leerink Downgrades Agios Pharma (AGIO) to Market Perform as Sickle Cell Program Delayed to 2022| AGIOS PHARM (NASDAQ: AGIO) | Delayed: 33.56 +0.09 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.47 | 52 Week High | $71.49 | |||
| Open | $33.10 | 52 Week Low | $33.50 | |||
| Day High | $33.81 | P/E | N/A | |||
| Day Low | $32.48 | EPS | $-1.18 | |||
| Volume | 1,124,479 | |||||
